Richard Fuller

Richard Fuller

Corporate Officer/Principal at
The Royal College of Physicians
Consumer Services
Health Technology
Miscellaneous

Profile

Richard Fuller is Chief Executive Officer of Oriel Therapeutics, Inc. and a Fellow of the Royal College of Physicians.
Prior to joining Oriel Therapeutics, he was Head of the Respiratory Clinical Group for Glaxo (now GlaxoSmithKline) and an Executive Director of the Wellcome Trust.
Previously, he was a Director and an Independent Consultant of Science Funding.
Dr. Fuller received a BSc degree in Immunology from University College London, an MBBS from the St. Georges Hospital Medical School London and an MD from the University of London.

Richard Fuller active positions

CompaniesPositionStart
Corporate Officer/Principal 17/04/2009

Former positions of Richard Fuller

CompaniesPositionEnd
Director/Board Member -
Founder -
Corporate Officer/Principal -
Chief Tech/Sci/R&D Officer -
See the detail of Richard Fuller's experience

Training of Richard Fuller

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

77

1st degree connections

7

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies7

Miscellaneous

Health Technology

Distribution Services

Consumer Services

Health Technology

Consumer Services

Consumer Services

  1. Stock Market
  2. Insiders
  3. Richard Fuller